Molecular and cellular phenotypic differences distinguish murine syngeneic models from human tumors | bioRxiv
Syngeneic Tumor Mouse Models: The Pros and Cons
Quantifying spontaneous metastasis in a syngeneic mouse melanoma model using real time PCR - Analyst (RSC Publishing)
Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models | Scientific Reports
aptCTLA-4 Inhibited In Vivo Tumor Growth in a Murine Syngeneic Tumor... | Download Scientific Diagram
Composition of CD4 T cell subsets and impact on tumor growth control across mouse syngeneic tumor models
Frontiers | Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges - ScienceDirect
New in vivo shuttle session: Syngeneic mouse tumor models for novel drug assessment and MoA deciphering - by Explicyte Immuno-Oncology
Subcutaneous Tumor Models - Creative Biolabs
Validation of syngeneic mouse models of melanoma... | F1000Research
Syngeneic Mouse Models | Oncology | genOway
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors | BMC Genomics | Full Text
Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies - ScienceDirect
Cells | Free Full-Text | Contemporary Mouse Models in Glioma Research | HTML
Preclinical models of immuno-oncology therapeutics
Syngeneic Tumor Models | Encyclopedia MDPI
Syngeneic Tumor Mouse Models: The Pros and Cons
Multimodality cellular and molecular imaging of concomitant tumour enhancement in a syngeneic mouse model of breast cancer metastasis | Scientific Reports